Dealmaking

KKR’s Bae: ‘Our best returns are in Japanese PE'

Japan is the firm’s second-largest destination for PE deployment, co-chief Joseph Bae told delegates at the HKMA’s 2024 Global Financial Leaders’ Investment Summit.

Disruption Matters: Embarking on the next era of value creation

In the finale of the Disruption Matters podcast series’ third season, we discuss the concrete steps to building a value creation program using this era's cutting-edge tech.

Blackstone to buy Jersey Mike’s Sub; MSCP acquires pet supplement company FoodScience

MSCP acquires vitamin company FoodScience.

Kohlberg to seek recap investors for PCI Pharma Services in early 2025, sources say

The PE firm is seeking a new investor in the company to support growth initiatives, which include building new production facilities.

MSCP bets nutritional supplements are the next big thing in pet care

Morgan Stanley Capital Partners has acquired FoodScience from Wind Point Partners, PE Hub is the first to report.

What could slow the shift to agentic AI

Experts from Insight Partners, Microsoft and IBM weigh in on the challenges that must be overcome before AI agents become commonplace in the enterprise.

Main Capital merges two financial admin businesses; Triton, Mutares make moves in busy logistics sector

Houlihan Lokey managing director Burke Smith explains private equity's interest in logistics.

KKR’s Pete Stavros, TPG’s Jon Winkelried to speak at NEXUS 2025; Investcorp, PSP back PKF O'Connor Davies

Private equity bets on accounting firms.

European tech dealmaking to pick up, says Houlihan Lokey’s Sascha Pfeiffer; Baird Capital hires for PE team

'We’re seeing a ray of light in the US market, and this generally means Europe isn’t far behind,' says Houlihan Lokey’s Sascha Pfeiffer.

Unlocking value by interrogating pharma spending – RxBenefits

Pharmacy spend is becoming a key value lever at US portfolio companies as PE firms up their focus on healthcare oversight, says RxBenefits’ Peter Lombardi.